Hibiclens
About HibiclensTriviaArticlesClinical InfoEducational ResourcesHibigeebies ImagesProduct Samples

2005 Germ of the Month:

Newman (Streptococcus pnemoniae)

Gilli (Aspergillus flavus)

Eli (Escherichia coli)

Elliot (Staphylococcus epidermidis)

Gus (Aspergillus fumigatus)

Shari (SARS)

Albert (Candida albicans)

Staphon (Staphylococcus aureus)

Sid ( Pseudomonas aeruginosa)

Rocco (Enterococcus faecium), Sal (Salmonella typhimurium) and Trip (Spirochaeta treponema pallidum)


Articles:

Persistant and Residual Antimicrobial Effects: Are They Important in the Clinical Setting? By Daryl S. Paulson, PhD. (PDF 222k)


Clinical Compendium:

Clean Scene InvestigationsStart with Hibiclens®
Any good investigation starts at the scene – in this case, your facility. Protect both patients and healthcare workers at your facility by killing the Hibigeebies - microorganisms that potentially can cause disease. Hibiclens kills germs on contact and continues to lower skin microbial counts with repeated use. Its 4.0% chlorhexidine gluconate (CHG) bonds with the skin to create a germ-killing field that keeps killing long after washing/scrubbing.

Hibiclens is indicated for use as:
• a surgical hand scrub
• a healthcare personnel hand wash
• a patient pre-operative skin preparation
• a wound cleanser and general skin cleaner

Gentle yet powerful, Hibiclens is compatible with the normal pH of the skin and ideal for use several times a day.

Hibiclens keeps working when you’re not
Hibiclens (4.0% CHG) is the most effective antimicrobial wash providing the longest protection – up to six hours per use1 – that is not neutralized by blood or other organic material.2

The evidence is in – nothing works like Hibiclens
Others have tried to imitate Hibiclens with “me too” products. No one has succeeded.

Hibiclens kills the Hibigeebies . . . giving you and your facility one less thing to worry about.



Clinical Compendium PDFs
Click on the following links to download indiviual sections from our clinical compendium or download the complete compendium.

Hand Irritation Study - pgs. 2-3 (PDF 144k)

Hibiclens vs. Alcohol Study - pgs. 4-5 (PDF 156k)

Blood Neutralization Study: Hibiclens vs. Other Antiseptics - pgs. 6-7 (PDF 160k)

MRSA In Vitro Testing - pgs. 8-9 (PDF 268k)

CA-MRSA In Vitro Testing - pgs. 10-11 (PDF 180k)

MRSA Clostridium difficile (vegetative) Time-Kill Study - pgs. 12-13 (PDF 208k)

Avian Flu (H5N1) vs. Hibiclens Study - pgs. 14-15 (PDF 156k)

50 Microbes-Tentative Final Monograph (TFM) Testing - pgs. 16-17 (PDF 260k)

Hand Imprint Study - pgs. 18-19 (PDF 188k)

First and Last Wash of the Day Study - pgs. 20-21 (PDF 212k)

Hibi Vocabulary - pgs. 22-23 (PDF 84k)

Hibiclens Product Overview - pgs. 24-25 (PDF 116k)

Complete Compendium (PDF 2M)



1 Protocol # 030917-150
2 Regent Medical Study #040907-150


Hibiclens, the Hibiclens logo, Hibistat, the Hibistat logo, Hibigeebies, the Mölnlycke logo, and Mölnlycke are registered trademarks
of Mölnlycke Group of companies. Distributed by Mölnlycke Health Care US, LLC, Norcross, Georgia 30092.
©2007 Mölnlycke Health Care AB. All rights reserved. 1.800.843.8497 www.molnlycke.com